Anna-Lena Ullrich

Anna-Lena Ullrich

Auto-generated profile, based on publicly available information

Anna-Lena Ullrich

Institute of Transplant Immunology Hannover Medical School Hannover Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SSStefan Schlößer
Stefan Schlößer
AUAnna-Lena Ullrich
Anna-Lena Ullrich
NMNastaran Fazel Modares
Nastaran Fazel Modares
Matthias A. SchmitzMatthias A. Schmitz
Matthias A. Schmitz
JSJohannes Schöneich
Johannes Schöneich
MHMathias W. Hornef
Mathias W. Hornef
Postnatal establishment of enteric metabolic, host–microbial and immune homeostasis is the result of precisely timed and tightly regulated developmental and adaptive processes. Here, we show that infection with the invasive enteropathogen Salmonella Typhimurium results in accelerated maturation of the neonatal epithelium with premature appearance of antimicrobial, metabolic, developmental, and regenerative features of the adult tissue. Using conditional Myd88-deficient mice, we identify the critical contribution of immune cell-derived mediators. Cytokine stimulation of neonatal intestinal epithelial stem cell organoids suggests a network of synergistic and antagonistic cytokine effects with a significant contribution of IL-22, IL-4/IL-13, TNF, and IL-6 to infection-induced enterocyte reprogramming. Our findings demonstrate that the infection-associated immune cell activation disrupts physiological postnatal tissue maturation and may thereby worsen clinical outcomes and alter the neonatal-adult transition.

29 March 2026 in European Journal of Immunology
Verified
Journal Article
Open access
LRLouisa Ruhl
Louisa Ruhl
IPIsabell Pink
Isabell Pink
ECEvgeny Chichelnitskiy
Evgeny Chichelnitskiy
NDNora Drick
Nora Drick
ASAndrea Sauer
Andrea Sauer
CFChristine S. Falk
Christine S. Falk
SARS‐CoV‐2 infection can lead to persistent symptoms (i.e., long/post‐COVID), especially in unvaccinated individuals. Little is known about the sustained impact of acute severe COVID‐19 on immune signatures and long/post‐COVID symptoms, often associated with cardiovascular events and pulmonary impairment. The longitudinal cohort (LC) was obtained from N = 46 patients with previous severe COVID‐19 and prior to SARS‐CoV‐2 vaccination, collected over 5 visits up to 12 months after discharge ( n = 139). Long/post‐COVID status was assessed by lung function and fatigue scores. Blood was analysed regarding immune cell profiles, SARS‐CoV‐2 antibodies, and autoantigens. LC patients were compared with 39 acute severe COVID‐19 ICU patients and 28 unexposed pre‐pandemic donors (UE) and correlated with clinical parameters. LC patients exhibited long‐term decreased CD4 + /CD8 + T cell ratio, differentiation from naïve to TEMRA, CD57 + CCR7 − memory, and HLA‐DR + CD38 + activated CD4 + and CD8 + T cells. LC plasma profiles displayed elevated levels of markers for chronic inflammation and endothelial injury. Chronic inflammatory chemokines and cardiovascular markers remained high. These markers and autoantibodies against centromere structures negatively correlated with lung function. At 1‐year post‐discharge, LC patients with a COVID‐19 ICU history displayed sustained significant changes in their immune profile at cellular and inflammatory levels, revealing signatures of persistent inflammation and endothelial injury.